Covid global health emergency is over, WHO says
Close to 20 million people are likely to have died during the last three years, says the WHO.
Similar Posts
Flu and COVID-19 infections rise ahead of holiday gatherings
Flu and COVID-19 infections rise ahead of holiday gatherings – CBS News Watch CBS News An increase in COVID-19 and flu infection rates could get worse in coming weeks, fueled by holiday gatherings and low vaccination rates. CBS News’ Lilia Luciano shares what you can do to keep yourself and your loved ones safe. Be…
Possible Ozempic side effects including hair loss and suicidal thoughts probed by FDA
The Food and Drug Administration is looking into whether three possible health issues or side effects, including hair loss and thoughts of suicide, might be linked to a group of medications that have boomed in popularity for their use in weight loss, including Ozempic, Wegovy, Mounjaro and Zepbound. The probe into these issues was disclosed…
How some Indian hospitals are cutting cancer drug costs
Baby Nandi, 58, is waiting for her next chemotherapy session at the Cachar hospital clinic. Previously, she had to travel 2,000km (1,242 miles) for breast cancer treatment. The drugs alone cost $650 for one treatment cycle. She needed six cycles. Along with the travel and accommodation costs, her family’s finances were pushed to the brink.
Pentagon waited three days to inform White House that the defense secretary was hospitalized in ICU
WASHINGTON — Amid tensions in the Middle East, Secretary of Defense Lloyd Austin was hospitalized, including spending four days in the intensive care unit, according to two senior administration officials. The Pentagon did not inform senior officials in the White House’s National Security Council of Austin’s hospitalization until Thursday — three days after he arrived…
To reduce cancer risk, skip the alcohol, report suggests: ‘No safe amount’
For those participating in “Dry January,” another potential benefit of giving up alcohol has emerged. Giving up alcoholic drinks — or reducing the amount that’s consumed — could reduce the risk of getting oral or esophageal cancer, according to a special report published in The New England Journal of Medicine on Dec. 28. Researchers from…
Prescriptions for Eli Lilly’s new weight-loss drug get off to a strong start and confirm bright outlook
The launch of Eli Lilly ‘s weight-loss drug Zepbound — a key pillar of our investment thesis in the pharmaceuticals giant — is going swimmingly in the U.S., Jefferies said Friday. Weekly Zepbound prescriptions totaled 7,700 in the week ended Dec. 8, its fourth on the U.S. market, according to Jefferies, which cited data compiled…
